Navigation Links
Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
Date:9/3/2009

body mass index and weight compared to those on placebo.

"The novel mechanism of action, the positive efficacy results and the excellent safety profile, make Menerba an extremely promising drug candidate for postmenopausal women. While 40 million women in the United States suffer from hot flashes and night sweats leading to the second largest indication in Women's Health domestically, the opportunity is significantly increased when we factor in international opportunities. We look forward to introducing Menerba to a wider scientific, clinical and pharmaceutical community, where there is demonstrated interest in finding an alternative to hormone therapy on an international basis," said Dr. Mary Tagliaferri, M.D., President and Chief Medical Officer at Bionovo.

"I am very encouraged by the findings of this clinical trial. The novel mechanism of action and phase 2 efficacy and safety results are encouraging and warrant further investigation. Presuming the phase 3 results confirm the findings in the phase 2 trial, there seems no question that, if approved, Menerba's safety and efficacy profile could make it a first line therapy in an indication that clearly needs alternatives," said Wulf Utian, M.D., Ph.D., D.Sc., founder and President Emeritus of the North American Menopause Society and Menerba's phase 3 Principal Clinical Investigator.

Menerba

Menerba is an estrogen receptor (ER) beta selective drug developed as an alternative to postmenopausal hormone products currently on the market, which are both ER beta and ER alpha agonists that have been shown to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with ER alpha activation and that ER beta blocks the growth promoting effects on breast cancer cells. Bionovo recognized the opportunity to commercialize a product that would be equally effective
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
2. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
4. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
5. Bionovo to Present at the Cambria Capital Investor Meeting
6. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
7. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
8. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Presentation at the National Cancer Institute
10. Bionovo Announces Cost Control Measures Taken
11. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Florida Council on Compulsive Gambling, Inc. (FCCG), along with ... Education Center, Mental Health Association of Southeast Florida, and ... will hold its annual conference in Ft Lauderdale this ... This important event will address topics such as public ... training for problem gambling treatment services. “This year’s ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 MBLM ... creative and technology, announced today that its founder and ... by Shocase, a marketing professional network aimed at connecting ... , Widely regarded as a specialist in the corporate ... high-profile branding programs over the last three decades, including ...
(Date:5/6/2015)... 2015 In celebration of their twentieth anniversary, ... month they will give away a deluxe human hair lace ... few steps to enter on a third-party giveaway tool. The ... anyone can be the winner. , The hair is a ... the destination for such a jewel for the past 20 ...
(Date:5/6/2015)... 06, 2015 Most people in the United ... or other care after age 65. But less than half ... it or even talking about it, reports the May 2015 ... risk two problems. One is losing control over the care ... says Dr. David Grabowski, a professor of health care policy ...
(Date:5/6/2015)... Raleigh, NC (PRWEB) May 06, 2015 ... pembrolizumab recently reported what they are calling “unprecedented” tumor ... an article on the new research. Click here ... oncologists gave pembrolizumab to 25 mesothelioma patients between March ... AACR meeting in April. , “Pembrolizumab… provides robust antitumor ...
Breaking Medicine News(10 mins):Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2
... LAKE CITY U.S. and Swiss scientists have made ... blood cell called the eosinophil may help the body ... to research published online this week in Nature ... of Bern, Switzerland, Gerald J.Gleich, M.D., from the University ...
... the Internet Modeling and Simulation Network, is broadcasting complete video ... environments that were exhibited recently on Capitol Hill. Complete coverage ... link. , ... Arlington, VA ...
... common after war, studies show, , , TUESDAY, Aug. 12 (HealthDay ... effects of war linger long after the conflict ends. , ... American Medical Association is a special themed issue on ... issue found that various mental health issues, such as alcohol ...
... students arrive on,campus this fall, it,s a time ... will last a lifetime. Unfortunately for many, it ... with its aftermath-vandalism,violence, sexual aggression, and even death., ... to research summarized in a College Task Force ...
... entrepreneurial endeavor by a person with a disability, ... nonprofit,rehabilitation and resource center for people with disabilities, ... Award., Established in 1992, the Jacobson Award ... endeavor by a person with a,physical disability or ...
... provider of nationally-approved online continuing education (CE/CEU) ... other allied health professionals, has been selected ... a national provider of mental health services ... expansion into servicing the corporate/institutional arena. HFO,s ...
Cached Medicine News:Health News:White blood cell uses DNA 'catapult' to fight infection 2Health News:NTSA's SimTV.org Broadcasts Video from Modeling & Simulation Event on Capitol Hill 2Health News:NTSA's SimTV.org Broadcasts Video from Modeling & Simulation Event on Capitol Hill 3Health News:Drinking Problems Greater Among Returning Combat Veterans 2Health News:Drinking Problems Greater Among Returning Combat Veterans 3Health News:Fall Semester - A Time for Parents to Discuss the Risks of College Drinking 2Health News:Courage Center Seeks Applications for Judd Jacobson Memorial Award 2Health News:HealthForumOnline Named Vericare's Online Continuing Education (CE) Provider 2Health News:HealthForumOnline Named Vericare's Online Continuing Education (CE) Provider 3
(Date:5/6/2015)... 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ... the three-month period ended March 31, 2015. First quarter financial ... an increase of 19% as compared to $7.0 million ... revenues increased 41% year-over-year, enabled by the return of ... Serono in the fourth quarter of 2014; , ...
(Date:5/6/2015)... May 6, 2015 Woodford ... the Wellcome Trust and the Bill & Melinda ... Kymab, a leading monoclonal antibody biopharmaceutical company, ... additional US$50 million to complete a US$90 million ... invested by Woodford Patient Capital Trust plc (LSE:WPCT,"Woodford") ...
(Date:5/5/2015)... May 5, 2015  In line with CBME China,s ... the community with a charity program to create awareness, ... CBME China team is coordinating a ... maternity manufacturers, brand owners and distributors. All donated products ... 2015. Proceeds from the sale will be used to ...
Breaking Medicine Technology:Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4CBME China Launches Charity Program to Support Children with Autism 2
... Nov. 15, 2011 The National Bone Health Alliance (NBHA) ... reducing hip and other fractures by 20 percent by 2020 ... Permanente Center for Total Health on Capitol Hill. ... States. Of that number, approximately three-quarters are women. The combined ...
... PAUL, Minn., Nov. 15, 2011 Prime Therapeutics (Prime), ... will implement a retail medication therapy management (MTM) program ... fully-insured group and individual membership. The program ... of medication therapy management services at the point of ...
Cached Medicine Technology:Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020 2Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020 3Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020 4Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020 5Prime Therapeutics Launches Retail Medication Therapy Management Program 2Prime Therapeutics Launches Retail Medication Therapy Management Program 3
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
... includes fixed-volume, adjustable-volume, and multichannel models ... Research pro Pipette. Designed with a ... pipettes have earned a worldwide reputation ... with original Eppendorf pipette tips, they ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: